APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair

Blood

Volumn 120, Issue 2, 2012, Pages 366-375

  Nowarski, Roni ^a   Wilner, Ofer I ^b   Cheshin, Ori ^a   Shahar, Or D ^b   Kenig, Edan ^a   Baraz, Leah ^a   Britan Rosich, Elena ^a   Nagler, Arnon ^c   Harris, Reuben S ^d   Goldberg, Michal ^b   Willner, Itamar ^b   Kotler, Moshe ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE DEAMINASE; DOUBLE STRANDED DNA; GENOMIC DNA; HISTONE H3;

ARTICLE; CATALYSIS; CELL NUCLEUS; CELL SURVIVAL; CUTANEOUS T CELL LYMPHOMA; DNA FLANKING REGION; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IONIZING RADIATION; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MULTIPLE MYELOMA; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY;

EID: 84864028244     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-402123     Document Type: Article

References (46)

1. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature. 2000;408(6811):433-439.
2. Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461(7267):1071-1078.
3. Sonoda E, Hochegger H, Saberi A, Taniguchi Y, Takeda S. Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair (Amst). 2006;5(9):1021-1029. (Pubitemid 44291617)
4. Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. Cell Res. 2008;18(1):134-147.
5. Symington LS, Gautier J. Double-strand break end resection and repair pathway choice. Annu Rev Genet. 2011;45:247-271.
6. Lieber MR, Ma Y, Pannicke U, Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol. 2003;4(9):712-720. (Pubitemid 37082186)
7. Beucher A, Birraux J, Tchouandong L, et al. ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2. EMBO J. 2009;28(21):3413-3427.
8. Takata M, Sasaki MS, Sonoda E, et al. Homologous recombination and non-homologous endjoining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 1998;17(18):5497-5508. (Pubitemid 28427063)
9. San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008;77:229-257.
10. Chung WH, Zhu Z, Papusha A, Malkova A, Ira G. Defective resection at DNA double-strand breaks leads to de novo telomere formation and enhances gene targeting. PLoS Genet. 2010;6(5): e1000948.
11. Jarmuz A, Chester A, Bayliss J, et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics. 2002;79(3):285-296. (Pubitemid 34211936)
12. Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol. 2004;4(11): 868-877. (Pubitemid 39490762)
13. Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol. 2008;26:317-353. (Pubitemid 351600379)
14. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002;418(6898):646-650.
15. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 2003;424(6944):99-103. (Pubitemid 36834849)
16. Stopak K, de Noronha C, Yonemoto W, Greene WC. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell. 2003;12(3): 591-601. (Pubitemid 37222482)
17. Vartanian JP, Guetard D, Henry M, Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science. 2008;320(5873): 230-233. (Pubitemid 351521418)
18. Suspene R, Aynaud MM, Guetard D, et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci U S A. 2011;108(12):4858-4863.
19. Jais JP, Haioun C, Molina TJ, et al. The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab. Leukemia. 2008; 22(10):1917-1924.
20. Norman JM, Mashiba M, McNamara LA, et al. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol. 2011;12(10): 975-983.
21. Britan-Rosich E, Nowarski R, Kotler M. Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif. J Mol Biol. 2011;410(5):1065-1076.
22. Nowarski R, Britan-Rosich E, Shiloach T, Kotler M. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nat Struct Mol Biol. 2008;15(10):1059-1066.
23. Shahar OD, Ram EV, Shimshoni E, Hareli S, Meshorer E, Goldberg M. Live imaging of induced and controlled DNA double-strand break formation reveals extremely low repair by homologous recombination in human cells [published online ahead of print November 21, 2011]. Oncogene. doi:10.1038/onc.2011.516.
24. Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 1999;13(20):2633-2638. (Pubitemid 29508550)
25. Diggle CP, Bentley J, Kiltie AE. Development of a rapid, small-scale DNA repair assay for use on clinical samples. Nucleic Acids Res. 2003;31(15): e83.
26. Rudin CM, Thompson CB. Transcriptional activation of short interspersed elements by DNA-damaging agents. Genes Chromosomes Cancer. 2001;30(1):64-71.
27. Chiu YL, Witkowska HE, Hall SC, et al. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci U S A. 2006;103(42):15588-15593. (Pubitemid 44625636)
28. Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem. 2006;281(39):29105-29119. (Pubitemid 44507054)
29. Hultquist JF, Lengyel JA, Refsland EW, et al. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J Virol. 2011;85(21):11220-11234.
30. Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 2010;38(13):4274-4284.
31. Marenstein DR, Wilson DM 3rd, Teebor GW. Human AP endonuclease (APE1) demonstrates endonucleolytic activity against AP sites in single-stranded DNA. DNA Repair (Amst). 2004;3(5): 527-533. (Pubitemid 38482027)
32. Larson ED, Cummings WJ, Bednarski DW, Maizels N. MRE11/RAD50 cleaves DNA in the AID/UNG-dependent pathway of immunoglobulin gene diversification. Mol Cell. 2005;20(3):367-375. (Pubitemid 41572294)
33. Chelico L, Pham P, Calabrese P, Goodman MF. APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA. Nat Struct Mol Biol. 2006;13(5):392-399. (Pubitemid 43881578)
34. Jones SE, Miller TP, Connors JM. Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy. J Clin Oncol. 1989; 7(9):1186-1191. (Pubitemid 19220119)
35. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993; 328(14):1002-1006. (Pubitemid 23095683)
36. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998;339(1):21-26. (Pubitemid 28304493)
37. Rodier F, Coppe JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009;11(8):973-979.
38. Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A. 2003;100(9):5057-5062. (Pubitemid 36542657)
39. Aldridge DR, Radford IR. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res. 1998;58(13):2817-2824. (Pubitemid 28311913)
40. Lowenthal JW, Harris AW. Activation of mouse lymphocytes inhibits induction of rapid cell death by x-irradiation. J Immunol. 1985;135(2):1119- 1125. (Pubitemid 16237425)
41. North RJ. Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immuno-manipulation: preferential elimination of suppressor T cells allows sustained production of effector T cells. J Exp Med. 1986;164(5):1652-1666. (Pubitemid 17184195)
42. Chaudhuri J, Alt FW. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol. 2004;4(7):541-552. (Pubitemid 38931769)
43. Schrader CE, Linehan EK, Mochegova SN, Woodland RT, Stavnezer J. Inducible DNA breaks in Ig S regions are dependent on AID and UNG. J Exp Med. 2005;202(4):561-568. (Pubitemid 41186954)
44. Kavli B, Andersen S, Otterlei M, et al. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J Exp Med. 2005;201(12): 2011-2021. (Pubitemid 41002936)
45. Lee JH, Paull TT. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science. 2005;308(5721):551-554. (Pubitemid 40570585)
46. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci U S A. 2003; 100(3):776-781. (Pubitemid 36183906)